292
Participants
Start Date
July 31, 2000
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
dalteparin sodium
"Subject's randomize to treatment arm will receive dalteparin sodium 5,000 IU s.c. daily starting on randomization day until 20 weeks gestational age then;~dalteparin sodium 5,000 IU s.c. bid from 20 weeks to onset of labour or 37 weeks gestation (discontinued at the discretion of the investigator/obstetrician)~Within 24 hours of delivery, all subject's, regardless of randomization allocation will receive dalteparin sodium 5,000 IU s.c. daily for 6 weeks post-partum"
Saint Louis University, St Louis
University of Utah Health Sciences Centre, Salt Lake City
Royal Alexandra Hospital, Edmonton
QEII Health Sciences Centre, Halifax
Hamilton Health Sciences Centre, Hamilton
The Ottawa Hospital, Civic Campus, Ottawa
Mount Sinai Hospital, Toronto
Women's College Health Sciences Centre, Toronto
SMBD Jewish General Hospital, Montreal
St Mary's Hospital Centre, Montreal
CHA, Hopital Enfant Jesus, Québec
Royal University Hospital, Saskatoon
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Ottawa Hospital Research Institute
OTHER